What does DR. K. CAMPS do?

DR. K. CAMPS is a specialist medical practice in Boechout. Private Limited, started on 4 October 2005, 1 establishment.

What is the address of DR. K. CAMPS?

The registered office of DR. K. CAMPS is located at Weverstraat 59E, 2531 Boechout.

Is DR. K. CAMPS still active?

Yes. According to the CBE (30 October 2026) DR. K. CAMPS is active, legal situation “Normale toestand”, started on 4 October 2005.

Is DR. K. CAMPS registered on Peppol?

Yes, DR. K. CAMPS is registered on the Peppol network with ID 0208:0876451319.

What is the enterprise number of DR. K. CAMPS?

The enterprise number of DR. K. CAMPS is BE0876451319.

When was DR. K. CAMPS founded?

DR. K. CAMPS was founded on 4 October 2005.

Who are the directors of DR. K. CAMPS?

According to the 2025 annual accounts, the directors of DR. K. CAMPS are: Kim Camps.

Is DR. K. CAMPS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 October 2005; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. K. CAMPS make in 2025?

DR. K. CAMPS posted a profit after taxes of € 207,956 in financial year 2025.

What is the revenue of DR. K. CAMPS?

As a small company, DR. K. CAMPS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 278,131.

DR. K. CAMPS (Private Limited) - Boechout - BE0876451319

Dossier DR. K. CAMPS, printed on 30 October 2026 from databakkes.be/en/0876451319/dr-k-camps. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. K. CAMPS from Boechout, company number BE0876451319, closed financial year 2025 with a result of € 207,956 after tax. For that financial year DR. K. CAMPS recorded a gross margin of € 278,131 and equity of € 1.8 million. Compared with financial year 2024, the result moved from € 369,725 to € 207,956. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 22, 2026.

What it is worth Healthy

€ 1.8 million

▼ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 207,956

▼ 44% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.2 million

▲ 276% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 245,741 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 33,694

▼ 31% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 368

▲ 66% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,974

▲ 64% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 707,126 Gross margin 2022: € 707,126 First fiscal year in the series	€ 226,389 Gross margin 2023: € 226,389 ▼ 68% vs 2022 (€ 707,126) Unfavourable step	€ 507,995 Gross margin 2024: € 507,995 ▲ 124% vs 2023 (€ 226,389) Favourable step	€ 278,131 Gross margin 2025: € 278,131 ▼ 45% vs 2024 (€ 507,995) Unfavourable step	▼ 45%
Profit after taxes	€ 487,720 Profit after taxes 2022: € 487,720 First fiscal year in the series	€ 153,754 Profit after taxes 2023: € 153,754 ▼ 68% vs 2022 (€ 487,720) Unfavourable step	€ 369,725 Profit after taxes 2024: € 369,725 ▲ 140% vs 2023 (€ 153,754) Favourable step	€ 207,956 Profit after taxes 2025: € 207,956 ▼ 44% vs 2024 (€ 369,725) Unfavourable step	▼ 44%
Equity	€ 1,703,436 Equity 2022: € 1,703,436 First fiscal year in the series	€ 1,684,877 Equity 2023: € 1,684,877 ▼ 1% vs 2022 (€ 1,703,436) Unfavourable step	€ 1,872,695 Equity 2024: € 1,872,695 ▲ 11% vs 2023 (€ 1,684,877) Favourable step	€ 1,834,910 Equity 2025: € 1,834,910 ▼ 2% vs 2024 (€ 1,872,695) Unfavourable step	▼ 2%
Total debts	€ 26,515 Total debts 2022: € 26,515 First fiscal year in the series	€ 4,696 Total debts 2023: € 4,696 ▼ 82% vs 2022 (€ 26,515) Favourable step	€ 9,507 Total debts 2024: € 9,507 ▲ 102% vs 2023 (€ 4,696) Unfavourable step	€ 8,393 Total debts 2025: € 8,393 ▼ 12% vs 2024 (€ 9,507) Favourable step	▼ 12%
Cash	€ 1,149,376 Cash 2022: € 1,149,376 First fiscal year in the series	€ 270,868 Cash 2023: € 270,868 ▼ 76% vs 2022 (€ 1,149,376) Unfavourable step	€ 329,609 Cash 2024: € 329,609 ▲ 22% vs 2023 (€ 270,868) Favourable step	€ 1,237,762 Cash 2025: € 1,237,762 ▲ 276% vs 2024 (€ 329,609) Favourable step	▲ 276%
Retained profit	€ 1,689,176 Retained profit 2022: € 1,689,176 First fiscal year in the series	€ 1,670,617 Retained profit 2023: € 1,670,617 ▼ 1% vs 2022 (€ 1,689,176) Unfavourable step	€ 1,858,435 Retained profit 2024: € 1,858,435 ▲ 11% vs 2023 (€ 1,670,617) Favourable step	€ 1,820,650 Retained profit 2025: € 1,820,650 ▼ 2% vs 2024 (€ 1,858,435) Unfavourable step	▼ 2%
Dividend	€ 228,085 Dividend 2022: € 228,085 First fiscal year in the series	€ 172,314 Dividend 2023: € 172,314 ▼ 24% vs 2022 (€ 228,085) Unchanged	€ 181,907 Dividend 2024: € 181,907 ▲ 6% vs 2023 (€ 172,314) Unchanged	€ 245,741 Dividend 2025: € 245,741 ▲ 35% vs 2024 (€ 181,907) Unchanged	▲ 35%
Balance sheet total	€ 1,729,951 Balance sheet total 2022: € 1,729,951 First fiscal year in the series	€ 1,689,572 Balance sheet total 2023: € 1,689,572 ▼ 2% vs 2022 (€ 1,729,951) Unchanged	€ 1,882,202 Balance sheet total 2024: € 1,882,202 ▲ 11% vs 2023 (€ 1,689,572) Unchanged	€ 1,843,304 Balance sheet total 2025: € 1,843,304 ▼ 2% vs 2024 (€ 1,882,202) Unchanged	▼ 2%

Key figures of DR. K. CAMPS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. K. CAMPS?

What happened at DR. K. CAMPS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 22, 2026 New annual accounts for financial year 2025: profit of € 207,956 (▼ 44% vs 2024). filed late Source: NBB ↗
Oct 4, 2005 New establishment in Boechout. KBO
Oct 4, 2005 Start of the company according to the CBE. KBO

In short

From € 487,720 profit in 2022 to € 207,956 profit in 2025.

Paid € 545,193 in corporate taxes since 2022.

Best year ever: 2022, with € 487,720 profit.

Paid out € 828,046 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Kim Camps

DR. K. CAMPS

Klinisch Biologen ZAS 4.8%

Behind DR. K. CAMPS is Kim Camps. It owns 4.8% of Klinisch Biologen ZAS itself.

Directors

According to the 2025 annual accounts

Kim Camps

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Weverstraat 59E

2531 Boechout

2.182.986.087

Weverstraat 59 box E

2531 Boechout

Active since 4 October 2005

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0876.451.319
VAT number: BE 0876.451.319
Registered office: Weverstraat 59E, 2531 Boechout
Names & denominations: DR. K. CAMPS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 October 2005
Peppol: Active · Active since 21 Oct 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗